H
HOOKIPA Pharma D
D
HOOK
1.49000
USD
-0.12
(-7.45%)
مغلق
حجم التداول
101
الربح لكل سهم
-3
العائد الربحي
-
P/E
-0
حجم السوق
18,151,760
الأخبار المقالات
العنوان: HOOKIPA Pharma Inc.
القطاع: Healthcare
الصناعة: Biotechnology
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program,HB-500, are being developed in partnership with Gilead.